Fast Start for FDA Drug Approvals in 2017
By Michael Mezher -
Published 12 April 2017
The US Food and Drug Administration (FDA) is poised to make a comeback from the relatively low number of new drugs approved in 2016, though it's unlikely to match the approval highs from 2014 and 2015.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Submission and registration
Tags: Approvals, New Molecular Entities, Biologics License Applications